Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2597
Source ID: NCT00111540
Associated Drug: Exenatide
Title: Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: exenatide
Outcome Measures: Primary: Change in HbA1c (glycosylated hemoglobin) from Visit 1 to each protocol visit, Change in HbA1c from Visit 1 to each visit up to open-ended study termination, Day 1, Weeks 2, 4, 8, 15, 22, 30, 38, 46 and every 12 weeks while on study (78 week target)|Change in body weight from Visit 1 to each protocol visit, Change in body weight (kg) from Visit 1 to each visit up to open-ended study termination, Day 1, Weeks 2, 4, 8, 15, 22, 30, 38, 46 and every 12 weeks while on study (78 week target)|Change in fasting plasma glucose from Visit 1 to each protocol visit, Change in fasting plasma glucose from Visit 1 to each visit up to open-ended study termination, Day 1, Weeks 2, 4, 8, 15, 22, 30, 38, 46 and every 12 weeks while on study (78 week target)|Change in lipids from Visit 1 to each protocol visit, Change in lipids from Visit 1 to each visit up to open-ended study termination, Day 1, Weeks 2, 4, 8, 15, 22, 30, 38, 46 and every 12 weeks while on study (78 week target) |
Sponsor/Collaborators: Sponsor: AstraZeneca
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 456
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2002-11
Completion Date: 2006-09
Results First Posted:
Last Update Posted: 2015-02-23
Locations: Research Site, Birmingham, Alabama, United States|Research Site, Anaheim, California, United States|Research Site, Bellflower, California, United States|Research Site, Burlingame, California, United States|Research Site, Chula Vista, California, United States|Research Site, Concord, California, United States|Research Site, Encino, California, United States|Research Site, Fremont, California, United States|Research Site, La Jolla, California, United States|Research Site, Los Gatos, California, United States|Research Site, Moreno Valley, California, United States|Research Site, Redwood City, California, United States|Research Site, San Mateo, California, United States|Research Site, Walnut Creek, California, United States|Research Site, Aurora, Colorado, United States|Research Site, Denver, Colorado, United States|Research Site, Gainesville, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Largo, Florida, United States|Research Site, Maitland, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Ocala, Florida, United States|Research Site, Blairsville, Georgia, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Chicago, Illinois, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Lexington, Kentucky, United States|Research Site, Covington, Louisiana, United States|Research Site, New Orleans, Louisiana, United States|Research Site, Slidell, Louisiana, United States|Research Site, Detroit, Michigan, United States|Research Site, Edina, Minnesota, United States|Research Site, Minneapolis, Minnesota, United States|Research Site, Gulfport, Mississippi, United States|Research Site, Picayune, Mississippi, United States|Research Site, Chesterfield, Missouri, United States|Research Site, St. Louis, Missouri, United States|Research Site, Butte, Montana, United States|Research Site, Las Vegas, Nevada, United States|Research Site, New York, New York, United States|Research Site, Rochester, New York, United States|Research Site, Cary, North Carolina, United States|Research Site, Durham, North Carolina, United States|Research Site, Columbus, Ohio, United States|Research Site, Marion, Ohio, United States|Research Site, Maumee, Ohio, United States|Research Site, Mentor, Ohio, United States|Research Site, Clinton, Oklahoma, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Medford, Oregon, United States|Research Site, Portland, Oregon, United States|Research Site, Camp Hill, Pennsylvania, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Midland, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Salt Lake City, Utah, United States|Research Site, Olympia, Washington, United States|Research Site, Spokane, Washington, United States
URL: https://clinicaltrials.gov/show/NCT00111540